Connect with us

Health

3rd Award Ceremony of the Paediatric Heamatology and Oncology Fellowship:  Profiles of the Fellows

Published

on

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH), established the Paediatric Haematology and Oncology Fellowship (PHO) Program to build capacity and strengthen care for children with cancer and blood disorders across the country and the region.

Since its inception in 2016, 24 pediatricians have been trained by the program and now serve as leaders in Paediatric Haematology and Oncology clinical services across ten hospitals in seven countries in Africa. This marks a remarkable transformation from just two trained paediatric oncologists in Uganda in 2016 and has contributed to significantly improved survival rates for children with cancer and blood disorders.

On the 30th July 2025, 16 Fellows of the PHO Fellowship received their awards after a two-year stint on the fellowship. Below are their profiles

2018/2020 Cohort

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Nana Nakiddu is a Paediatric Haematologist and Oncologist and lecturer at Muhimbili University of Health and Allied Sciences/Muhimbili National Hospital in Tanzania. Her career focus is on developing innovative models for the delivery of childhood cancer survivorship care in low- and middle-income countries, particularly in sub-Saharan Africa, where cancer survivorship care is still in its early stages despite major advancements in access to diagnosis and treatment. Her ultimate career goal is to lead research and care initiatives for the growing population of childhood cancer survivors across Africa. She is passionate about sports and has represented Uganda internationally in swimming. As a qualified sports medicine physician, she contributes to the field both nationally and globally. She currently serves as the Secretary General of the Uganda Society for Sports Medicine and is the immediate past chairperson of the Uganda Olympic Committee’s Medical and Anti-Doping Commission.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Heronima Joas Kashaigili is a Pediatric Hematologist and Oncologist at Bugando Medical Centre and a lecturer Catholic University of Health and Allied Sciences in Mwanza Tanzania. She is the Assistant Head of Oncology Services and leads the Pediatric Hematology and Oncology Unit at Bugando Medical Centre. She is recognized nationally as a mentor and leader in advancing pediatric cancer care to improve survival outcomes through capacity-building initiatives.

Dr. Kashaigili earned her medical degree from the Catholic University of Allied and Health Sciences in 2009. She specialized in Pediatrics and Child Health at Kilimanjaro Christian Medical College in 2017 and completed a fellowship in Pediatric Hematology and Oncology at Makerere University College of Health Sciences in 2020 with support from the Texas Children’s Global HOPE program. She also has training and experience in clinical research and is currently pursuing a Master of Science in Global Child Health (MSGCH).

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Deborah Omeddo is a Paediatric haematologist and oncologist at Kisii teaching and Referral hospital and an adjunct lecturer at both the Kenya Medical Training college and Kisii University in Kenya. She has practiced as a paediatrician for the last 15 years during which she has keenly participated in research and clinical care of children. She has a passion for childhood haematological care and especially in Sickle cell disease. She has been a keen advocate for access of affordable care for sickle cell disease patients and is a patron of a number of the Sickle cell disease foundations. She has served in the Kenya paediatric association board where she advocated for childhood malnutrition and access to nutritional supplements. She is a member of the Kenyan ministry of health technical working group on childhood cancer where she has participated in development of management policy and guidelines. Her career goal has been to improve the research and clinical management of Sickle cell and other haematological disorders among children in sub-Saharan Africa.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Anne Akullo is a Pediatric Hematologist and oncologist and the current President of the Uganda Pediatric Association. She is the Associate Director of Clinical Operations for the Texas Children’s Hospital Global HOPE (TCH-GH) supported programs in Africa, where she leads the  Dissemination and Implementation Science program. She is passionate about advocacy for child health and uses the UPA platform to promote high-impact policies for child health initiatives, such as the scale-up of sickle cell disease care on a national scale. Dr. Akullo completed her medical degree from Makerere University College of Health Sciences in 2005, followed by a specialization in Paediatrics and Child Health at Makerere University College of Health Sciences in 2014. She completed a Fellowship in Pediatric Hematology and Oncology at the same institution in 2020, supported by Texas Children’s Global HOPE. In addition, she has training and experience in Project Management, Implementation Science, and child health advocacy.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Irene Nzamu is the Head the Pediatric Haematology and Oncology Unit at Kenyatta National Hospital (KNH) and an honorary lecturer in the Department of Paediatrics in the University of Nairobi. Dr. Nzamu chairs the Hospital Blood Transfusion Committee and is deputy chair of the Hospital Ethics Committee. Nationally, Dr. Nzamu is the paediatric lead in the Focal Team for the Kenya National Cancer Control Strategy, is a member of the Ministry of Health’s Technical Working Group on Childhood Cancer and is actively involved in the establishment of the Kenya Pediatric Hematology and Oncology Society. She has served as Treasurer in the Kenya Society of Hematology Oncology (KESHO).

She earned her both her undergraduate and post graduate degrees from the University of Nairobi in 2005 and 2012 respectively. She completed the clinical fellowship in pediatric hematology and oncology training at Makerere University College of Health Sciences supported by Texas Children’s Global HOPE in 2020. She is a graduate of the African Leadership University Public Sector leadership fellowship and has undertaken several trainings from the University of Washington. She is passionate about providing evidence-based childhood cancer care targeting to bridge the gap in survival for children in Low Middle-Income Countries.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Ankunda is a Pediatric Hematologist and Oncologist based at the Cancer Center of Mbarara Regional Referral Hospital (MRRH) in Western Uganda. She previously served as a lecturer in the Department of Pediatrics and Child Health at Kabale University. She has spearheaded numerous childhood cancer awareness campaigns and conducted research focused on understanding the reasons for treatment abandonment among children with cancer. Her research interest is in solid tumors with a focus on understanding their biology in sub-Saharan Africa and improving the survival of children affected by solid tumors.

Dr. Ankunda earned her medical degree from Makerere University College of Health Sciences in 2010, followed by a specialization in Paediatrics and Child Health at Mbarara University of Science and Technology in 2017. She completed a Fellowship in Pediatric Hematology and Oncology at Makerere University College of Health Sciences in 2020, supported by Texas Children’s Global HOPE.

2019/2021 Cohort

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Innocent Adebayo graduated with a medical degree (MBBS) from the University of Ilorin, Nigeria in 2006 and completed his residency in Paediatrics at the University of Abuja Teaching Hospital in 2018 with a Fellowship in Paediatrics (FMCPaed). Dr Adebayo’s completed his Paediatric Haematology and Oncology Fellowship Training in in 2021 from Makerere University College of Health Sciences, supported by the Texas Children’s Hospital Global HOPE program. He recently, in 2024, obtained a Fellowship in Palliative Medicine from the Institute of Palliative Medicine in India/St Christopher’s Hospice in London, United Kingdom. Dr Adebayo’s areas of interest are newborn screening, disease severity and hematopoietic stem cell transplantation in Sickle Cell Disease.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Rizine Mzikamanda is a specialist consultant in Pediatrics and Pediatric Hematology and Oncology at Baylor College of Medicine Children’s Foundation Malawi and Malawi National Cancer Center at Kamuzu Central Hospital (KCH). He is the Medical Director of the Global Hematology Oncology Pediatric Excellence Program in Malawi.

Dr. Mzikamanda completed his medical degree at the University of Malawi, College of Medicine (now Kamuzu University of Health Sciences- KUHES) in 2010, specialization in pediatrics at the University of Malawi, College of Medicine and University of Pretoria in 2018, and pediatric hematology and oncology fellowship at Makerere University in 2021 supported by Texas Children’s Global HOPE.

His vision is to become one of the leading clinical researchers in childhood leukemia and lymphoma in Sub-Saharan Africa (SSA). He is interested in developing locally appropriate treatment strategies for children in SSA and leading clinical trials in childhood cancer in this region over the next 5-10 years. 

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Catherine Muendo is a paediatric haematologist and oncologist working at the paediatric hematology and oncology department in Kenyatta National Hospital, Nairobi, Kenya. She is the head of unit at the Hemophilia comprehensive care centre at Kenyatta National Hospital. She is the vice chair of the Paediatric Hematology Oncology Society of Kenya.

She completed her medical degree at the University of Nairobi in 2010, and specialized training in paediatrics and child health at the University of Nairobi in 2017. She completed her paediatric hematology and oncology fellowship training at Makerere University College of Health Sciences, supported by Texas Children’s Global HOPE in 2021

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Emma Nsalazi Bambi is a Congolese paediatrician and subspecialist in paediatric haematology and oncology, currently pursuing a Clinical Fellowship in Transfusion Medicine at McMaster University in Hamilton, Ontario, Canada. He holds a Master of Medicine in Paediatrics and Child Health from Makerere University, Uganda, and completed fellowship training in Paediatric Haematology and Oncology at Makerere University College of health Sciences Texas Children’s Global HOPE.in 2021.Dr. Bambi began his medical career after obtaining his Doctor of Medicine degree from Goma University in the Democratic Republic of Congo, and specialized training in pediatrics and child health at Makerere University.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Annet Nakirulu completed her medical degree (MBChB) at Kampala International University in 2012, higher diploma in Paediatric palliative care at Mildmay Uganda in 2016, specialization in paediatrics at Uganda Martyrs University Post graduate School Nsambya in 2019 and pediatric hematology and oncology fellowship at Makerere University College of Health Sciences in 2021

Dr. Annet Nakirulu is an associate consultant in Pediatric hematology at the Directorate of Pediatrics at Mulago National Referral Hospital. She provides evidence-based interdisciplinary medical care to children with sickle cell disease, plans and leads Paediatric Hematology Oncology education and outreach activities within the local and national community. She also participates in research, clinical quality improvement and program monitoring and evaluation activities for children with cancer and blood disorders at Mulago National Referral Hospital in collaboration with Texas Children’s Hospital Global HOPE Program.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Moses Karashani began his medical journey at China Medical University, where he received comprehensive training in general Paediatrics and Child health. Driven by a passion for advancing care in childhood blood disorders, he pursued a fellowship in Paediatric Haematology and Oncology at Makerere University College of Health Sciences Texas Children’s Global HOPE, completing it in 2021

Currently, Dr. Karashani serves at the Muhimbili National Hospital, Mloganzila campus in Tanzania. His clinical and research interests focus on the management of both benign and malignant haematologic conditions in children, aiming to improve outcomes through evidence-based approaches and targeted therapies. His work bridges the gap between bedside care and academic inquiry, making him a vital contributor to Tanzania’s growing Paediatric haematology and oncology landscape.

Cohort 2020/2022

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Rose Munge is the Head of Unit -Paediatric Haematology and Oncology at Kenyatta University Teaching, Research and Referral Hospital (KUTRRH) and a lecturer in the Department of Paediatrics at Mount Kenya University. Dr. Munge played a key role in establishing paediatric oncology services at KUTRRH, culminating in the successful commissioning of the unit in 2024. She is also an active member of the Ministry of Health’s Technical Working Group on Childhood Cancer and is actively involved in the establishment of the Kenya Paediatric Haematology and Oncology Society. She earned her medical degree from the University of Nairobi in 2008 and completed specialized training in paediatrics at the same institution in 2015. In 2023, she completed a clinical fellowship in paediatric haematology and oncology at Makerere University College of Health Sciences supported by Texas Children’s Global HOPE. She also holds additional training in healthcare leadership from the University of Washington. Dr. Munge is passionate about expanding local fellowship training opportunities in paediatric haematology and oncology and is committed to advancing research-driven, high-quality cancer care for children across Kenya.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Catherine Nabaggala is a Paediatric Haematology and Oncology Specialist at Global HOPE (Haematology-Oncology Paediatric Excellence) Program in Uganda, based at Mulago National Referral Hospital. Dr Nabaggala completed her medical degree at Makerere University in 2004, specialized in Paediatrics at Makerere University Medical School in 2013 and Paediatric Haematology and Oncology fellowship at Makerere University in 2023 supported by Texas Children’s Global HOPE. Her vision is to scale up essential care for children with haematological disorders especially Sickle cell disease to the most vulnerable children living in primary health care settings.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr. Jennifer Zungu is the Director of The Texas Children’s Global HOPE program in Uganda. She holds a Bachelor of Medicine and Bachelor of Surgery from Makerere University, a Master of Medicine in Paediatrics and Child health from Mbarara University of Science and Technology (MUST), and a Diploma in Health care Management from The Kenya Institute of Management (KIM). She completed her clinical fellowship training in paediatric haematology and Oncology at Makerere University Supported by Texas Children’s Global HOPE.

Dr. Zungu is passionate and deeply committed to, driving better outcomes in Paediatric Haematology and Oncology. She uses her experience in healthcare management along with her clinical training in Paediatric Haematology-Oncology to advocate for evidence-based paediatric haematology and oncology care, best quality services, and excellent customer experience in the Public Healthcare sector in Uganda and beyond.

Makerere University College of Health Sciences (MakCHS) in collaboration with Texas Children’s Global Hospital, Baylor College of Medicine Children’s Foundation–Uganda, the Ministry of Health (MOH) of Uganda, and Mulago National Referral Hospital (MNRH) Paediatric Haematology and Oncology Fellowship (PHO) Program 16 Fellows Award ceremony 30th July 2025, Kampala Uganda, East Africa.

Dr.  Joseph Gore is Head of the Pediatric Hematology & Oncology Unit at Alsabbah Children Hospital in Juba, and Senior Lecturer at the University of Juba, with a focus on improving sickle cell disease care & oncology services in South Sudan.

View on CHS

Mak Editor

Health

Ekyaalo Diagnostics; Johns Hopkins University Partners with Makerere and MUST to Advance AI Innovation for Breast Cancer Diagnosis

Published

on

Group photo at Centre for Maternal, Newborn, and Child Health Research at Makerere University School of Public Health led by Associate Professor Peter Waiswa, alongside Graduate biomedical engineers from the Centre for Biomedical Innovation and Design (CBID) at Johns Hopkins University.

By Joseph Odoi

Globally, Breast cancer remains a serious health challenge, with the World Health Organization (2022) reporting over 2.3 million new cases annually and nearly 670,000 deaths. In Uganda, breast cancer is one of the leading cancers among women, yet the majority of patients are diagnosed at late stages due to delays in accessing diagnostic services, most of which are centralized at the Uganda Cancer Institute (UCI) in Kampala. Since 72% of Uganda’s population lives in rural areas, women often face late diagnosis due to long travel distances. Even after accessing care, results can take 1–6 months due to the slow process of transporting samples to central laboratories. This delay directly impacts the timely start of treatment.

To address this gap, Johns Hopkins University in collaboration with Makerere University and Mbarara University of Science and Technology (MUST), is spearheading innovative solutions that leverage artificial intelligence (AI) and low-cost technologies to improve early diagnosis and treatment.

As part of this collaboration, the Centre for Maternal, Newborn, and Child Health Research at Makerere University School of Public Health led by Associate Professor Peter Waiswa in July hosted a team of graduate biomedical engineers from the Center for Bioengineering Innovation and Design (CBID) at John Hopkins University.

The team is developing a low-cost, AI-powered technology called Ekyaalo Diagnostics, aimed at reducing the turnaround time for breast cancer diagnosis, especially in hard-to-reach areas. As part of their work, they undertook a learning tour at the Ministry of Health, Uganda Cancer Institute, and regional cancer referral centres. The purpose was to map stakeholders in the breast cancer space, gather Ekyaalo diagnostic technology usability feedback, and understand the local innovation ecosystem in breast cancer care.

Ekyaalo Diagnostics and Bringing Pathology Closer to Communities

The flagship innovation, Ekyaalo Diagnostics, is a portable AI-powered whole-slide scanner (WSS) designed to digitize cytology samples at Health Centre IVs and General Hospitals. These digitized images are securely transmitted to pathologists at higher-level facilities for timely review, eliminating the need for physically transporting samples to Kampala.

Ekyaalo Diagnostics hardware: A whole slide scanner and a Laptop displaying a scanned Image.
Ekyaalo Diagnostics hardware: A whole slide scanner and a Laptop displaying a scanned Image.

This technology has the potential to reduce diagnosis delays from several months to just a few days, thereby improving survival outcomes for breast cancer patients.

Building Local Solutions to Global Challenges

In addition to Ekyaalo Diagnostics, Makerere researchers at the Department of Biomedical Engineering are also advancing other innovations such as development of artificial breast prototypes to be used in  educating women on breast cancer symptoms while Research at Mbarara University led by Dr. William Waswa, are developing  PapsAI, a low-cost automated tool that support whole slide scanning of slides for cervical cancer screening.

These initiatives are aligned with the National Cancer Control Plan (NCCP) of the Ministry of Health, which emphasizes prevention, early detection, timely diagnosis.

Design Challenges and Considerations

Despite the progress being made, challenges persist, according to the team’s findings from the tour,these technologies hold great promise however their success in Uganda will depend on addressing some critical barriers.

One of the biggest challenges is limited staffing. Many lower-level health facilities lack trained laboratory personnel to prepare slides. For this reason, new technologies must be designed to be simple, user-friendly, and capable of being adopted after short training sessions.

Another major barrier is equipment maintenance. Past medical innovations in Uganda have often struggled with frequent breakdowns and software failures. The team emphasized that new diagnostic tools must be affordable, durable, and resistant to common system crashes if they are to serve rural health facilities effectively.

Finally, high operational costs continue to undermine sustainability. Some innovations fail because their maintenance costs are too high or because they are incompatible with existing health systems. Ensuring cost-effectiveness and system integration will therefore be vital for the long-term success of breast cancer diagnostic technologies in Uganda.

MORE ABOUT THE PROJECT

The project is led by the Johns Hopkins  Center for Bioengineering Innovation and Design (CBID) in collaboration with Makerere’s Department of Biomedical Engineering and MUST researchers. Field learning tours have already been conducted at Mulago National Referral Hospital, Jinja, Mbarara, and Fort Portal Regional Referral Hospitals, with input from clinicians, technologists, and innovators in Uganda’s health ecosystem.

The Johns Hopkins team has conducted usability interviews with clinicians, laboratory technologists, and surgeons at multiple hospitals including Mulago, Jinja, Mbarara, and Fort Portal. They have also engaged with Uganda’s innovation ecosystem, including makerspaces and industry partners. It has been noted that the Ministry of Health together with Partners working on treatment of cancer has drafted the National Cancer Control Plan (NCCP) that is aimed at reducing incidence, morbidity and mortality through prevention and early treatment and palliative care. The Plan will give guide on health education, early detection, and diagnosis among others Special thanks go to the Center for Bioengineering Innovation and Design   (CIBID) Johns Hopkins University for funding this field learning tour, Centre for Maternal Newborn and Child Health Research at School of Public health (Makerere University) for hosting the team, Departments of Bioengineering at Makerere University and Mbarara University of Science and Technology, Mulago pathology department and the Uganda cancer institute, Regional Referral hospitals of Jinja, Mbarara and Fort Portal among other General hospitals and Health center IVs visited for technical input.

Mak Editor

Continue Reading

Health

VectorCam Project; Makerere, Johns Hopkins, and MoH to Scale Up AI-Powered Malaria Surveillance across Uganda

Published

on

A multidisciplinary team from Makerere University School of Public Health and Johns Hopkins University during a courtesy visit to the Ministry of Health on 7th August 2025 to engage officials on the VectorCam Project-an innovative project focused on transforming how Uganda monitors malaria-carrying mosquitoes using a smartphone-based, AI-powered application that relies on computer vision to quickly identify mosquitoes by species, sex, and feeding status whether a mosquito has fed recently or not, Kampala Uganda, East Africa.

By Joseph Odoi

In a significant step toward revolutionizing mosquito surveillance in Uganda, Dr. Peter Waiswa, Associate Professor of Health Policy Planning and Management at the School of Public Health, Makerere University has revealed that a new AI-driven mosquito surveillance project is set to be rolled out to strengthen vector monitoring efforts across 22 districts in Uganda.

He disclosed this while briefing a multidisciplinary team during a courtesy visit to the Ministry of Health on 7th August 2025 to engage with officials on the VectorCam Project.

The VectorCam Project is a partnership between the Makerere University School of Public Health, Johns Hopkins University, and the Ministry of Health, with funding from the Gates Foundation. The project seeks to revolutionize mosquito surveillance by shifting from manual, human-led identification to a digital, AI-driven mobile application using computer vision

What is VectorCam?

VectorCam is an innovative project focused on transforming how Uganda monitors malaria-carrying mosquitoes. At its core is a smartphone-based, AI-powered application that uses computer vision to quickly identify mosquitoes by species, sex, and feeding status whether a mosquito has fed recently or not. Traditionally, such analysis requires the expertise of entomologists and takes considerable time.

According to Prof Waiswa, VectorCam will advance ento. surveillance.

‘’We have worked with Johns Hopkins University and the Minister of Health to develop an AI-powered mobile application which can be used to identify mosquitoes. This apps tells you the type of mosquito, the sex of the mosquito, and whether the mosquito has a full abdomen or half abdomen or is empty. That is, if it fed last night or not.

This one is a way to just shift mosquito surveillance from people to an app. The app does it in 20 seconds using computer vision. It does it faster and better than any entomologist. Every district just has one Entomologist. So the entomologist can go and focus on other things as part of his work because nowadays an app can do it.

The good thing with the app is we’ve already done a big trial funded by the Gates Foundation and we have evidence that it works. The app also posts data and makes it accessible through the DHIS to the districts but also at the national level’’ Prof. Waiswa explained.

‘’With support and funding from the Gates Foundation, we are going to be scaling up the Vector Cam Project to 22 districts. In 12 of these, we will conduct research to evaluate how the app actually performs at scale in routine life settings ‘’ Prof Waiswa stated about the next project step.

As part of the project engagement, Prof. Waiswa met with Dr. Daniel Kyabayinze, Director of Public Health at the National Malaria Control Division, Ministry of Health, Uganda, who also serves as the Acting Program Manager for Malaria at the National Malaria Control Program (NMCP) to brief him on the project genesis and its next objectives which will lead to data-driven decision making to tailor vector control interventions.

Also in attendance were also; Professor Soumyadipta Acharya a respected researcher in the field of ento. surveillance from Johns Hopkins University, United States, along with representatives from the Ministry of Health and Makerere University.

More About VectorCam Project

VectorCAM  is an innovative project focused on transforming how Uganda monitors malaria-carrying mosquitoes. At its core is a smartphone-based, AI-powered application that uses computer vision to quickly identify mosquitoes by species, sex, and feeding status.

Between November 2022 and April 2024, Makerere University, in partnership with Johns Hopkins University and Uganda’s National Malaria Control Programme (NMCP), successfully implemented the first phase of the VectorCam Project. Through this, the project piloted the VectorCAM an AI-driven mobile application that uses computer vision to identify mosquitoes by species, sex, and abdominal status providing rapid, cost-effective entomological surveillance in malaria-endemic regions.

Following the successful trial and validation of the technology, the project is now entering a new phase focused on scaling up.

VectorCam will be rolled out across 22 districts in Uganda, with operational research embedded in 12 of those districts to assess its performance.

Mak Editor

Continue Reading

Health

Prof. Serwadda Urges Shift from Transactional to Equitable Research Partnerships

Published

on

Seated: Prof. David Musoke Serwadda (2nd Right) and Assoc. Prof. David Musoke (3rd Right) with participants at the workshop on 20th August 2025. Workshop on Strengthening Equitable Partnerships in International Research Collaboration in Uganda, keynote address by Prof. David Musoke Serwadda,20th August 2025, Makerere University School of Public Health (MakSPH) Auditorium, Kampala Uganda, East Africa.

On August 20, 2025, Makerere University School of Public Health (MakSPH) convened a timely workshop on Strengthening Equitable Partnerships in International Research Collaboration in Uganda. Held at the MakSPH Auditorium, the event brought together researchers, policymakers, and institutional leaders to reflect on how Uganda, and indeed the wider region, can engage more effectively and derive greater benefit from global research collaborations.

Delivering the keynote address, Prof. David Musoke Serwadda, a Professor Emeritus at Makerere University and a globally recognised HIV researcher and epidemiologist, urged a rethinking of how international research partnerships are structured. A former head of the Institute of Public Health (IPH) and later Dean of the School, serving between 2003 and 2009, Serwadda is also the founding director of the Rakai Health Sciences Programme (RHSP), which is one of Uganda’s most influential research initiatives on HIV. While acknowledging the many benefits Uganda has gained from global research collaborations, he cautioned that too many times, these partnerships remain transactional, shaped by donor priorities, bound to project cycles, and offering limited long-term value to local institutions once projects close.

Prof. Serwadda, himself a globally recognised and well-accomplished researcher, with over four decades of experience and numerous awards for his contributions to science and global health, observed that Ugandan partners are many times included in research projects for visibility rather than substance, often excluded from core roles such as Principal Investigators or from influencing agenda-setting, budget control, and authorship. “Partnerships are not an end in themselves; they exist to help us achieve mutually agreed objectives built on shared responsibility and reciprocal obligations. Too often, Southern institutions are brought into projects late, simply for optics. That is not equitable collaboration,” he insisted.

Prof. David Musoke Serwadda delivering his keynote address on Strengthening Equitable Partnerships in International Research Collaboration in Uganda. August 20, 2025. Workshop on Strengthening Equitable Partnerships in International Research Collaboration in Uganda, keynote address by Prof. David Musoke Serwadda,20th August 2025, Makerere University School of Public Health (MakSPH) Auditorium, Kampala Uganda, East Africa.
Prof. David Musoke Serwadda delivering his keynote address on Strengthening Equitable Partnerships in International Research Collaboration in Uganda. August 20, 2025.

During his talk, he stressed that this imbalance undermines both research quality and sustainability, noting that normally, when local researchers are sidelined, studies often fail to align with national priorities or build capacity that endures. By contrast, partnerships that are grounded in mutual respect, fair resource sharing, co-design, and shared decision-making have the impact of producing knowledge that is globally relevant and locally impactful.

“Equity in partnerships is about fairness, ensuring that all partners, regardless of context, can contribute meaningfully. This also requires responsibility on our part in the Global South. We must insist on involvement from project conception, negotiate fair terms, and strengthen our own systems to manage collaborations effectively,” Prof. Serwadda advised, emphasising that strong institutions, clear strategy, agenda and objectives are key for local institutions to engage in mutually fair and beneficial research collaborations at the global and continental stage.

As Director and later Dean of MakSPH, Prof. David Serwadda spearheaded numerous research collaborations and attracted substantial grants that elevated the School and the University’s global standing. Today, MakSPH is recognised as Makerere University’s flagship unit for its wide-ranging partnerships and robust research management systems. Since its beginnings as a small Department of Preventive Medicine in 1954, through its transformation into the first Institute of Public Health in sub-Saharan Africa in 1975, its elevation to School status in 2007, and most recently its reinstatement as a standalone School with college status within Makerere University in January 2025, a status first granted in 2001, MakSPH has built a 70-year legacy of advancing public health through research, training, and policy engagement.

The School’s evolution, as often couched by its leadership, has been anchored on strategic and strong partnerships. These collaborations, be they local, regional or global, have driven health systems innovation, strengthened capacity, and informed policy, making partnerships the cornerstone of the School’s past achievements and future ambitions. At the celebration of the School’s 70th Anniversary, marked in December 2024, Makerere University Vice Chancellor Prof. Barnabas Nawangwe hailed MakSPH’s research output, community impact, and strong partnerships cultivated throughout the years. The Mak VC cited the School’s pioneering role in the HIV response led by Prof. Serwadda in the 1980s, the establishment of nutrition centres such as the Mwana Mugimu Unit at Mulago Hospital and across Uganda by the late Prof. John Kakitahi in the 1990s with support from Rotary International, and community projects like Kasangati Health Centre along Gayaza Road with support from the Rockefeller Foundation in the late 1950s, which advanced public education on healthy environments and wellness.

Current MakSPH building (left) and the new eight-storey facility under construction (right) near Eastern gate, Makerere University, developed through strong partnerships, including generous support from the American people via the USAID ASHA Program, to meet the School’s growing space and infrastructure needs.
Current MakSPH building (left) and the new eight-storey facility under construction (right) near Eastern gate, Makerere University, developed through strong partnerships, including generous support from the American people via the USAID ASHA Program, to meet the School’s growing space and infrastructure needs.

“The School of Public Health brings in almost half of all research grants at Makerere University, both in number and value, and these partnerships have been central to tackling Uganda’s public health challenges. From pioneering HIV/AIDS work that shaped global prevention strategies to interventions in maternal health, malaria, and infectious diseases, MakSPH has consistently combined academic excellence with community service. Its leadership during the COVID-19 pandemic further showed its ability to respond to national health emergencies with evidence-based solutions that directly benefit the people,” Prof. Nawangwe said with gratitude for the work done by the School through collaboration.

Makerere University Vice Chancellor, Prof. Barnabas Nawangwe, exchanges documents with UNICEF Uganda Representative, Dr. Robin Nandy, during the signing of an MoU on August 14, 2025. The two-year renewable partnership seeks to advance child rights and well-being, a critical public health priority in Uganda.
Makerere University Vice Chancellor, Prof. Barnabas Nawangwe, exchanges documents with UNICEF Uganda Representative, Dr. Robin Nandy, during the signing of an MoU on August 14, 2025. The two-year renewable partnership seeks to advance child rights and well-being, a critical public health priority in Uganda.

In 2024, the School had over 350 peer-reviewed publications in high-impact international journals as a result of this wide network and partnerships. MakSPH currently maintains a strong mix of North–South and South–South collaborations. Within the continent, the School is actively working in more than 25 countries, often partnering with multiple institutions within individual countries to advance research, capacity building, and policy influence. One such recent collaboration is the Partnership to Enhance Technical Support for Analytical Capacity and Data Use in Eastern & Southern Africa (PERSuADE) Project, funded by the Global Fund. Under PERSuADE, MakSPH, the prime grant recipient, hosted the secretariat led by Dean Prof. Rhoda Wanyenze as Principal Investigator, tasked with overall coordination across 12 countries, while a Steering Committee chaired by Prof. David Serwadda provided oversight.

PERSuADE was implemented in two phases between 2018 and 2023. The project brought together 12 universities and 12 Ministries of Health in East and Southern Africa to strengthen analytical capacity and promote data use in national health programmes, cascading skills to districts and lower facilities. In its second phase, the project trained over 1,500 health staff, including 934 at the sub-national level, in data analysis and use, and generated more than 80 analytical outputs on HIV, TB, and malaria. These informed National Strategic Plans in seven countries and improved programme strategies in all 12. Sixteen in-service staff from seven countries received specialised training in HIV key population surveillance, health information systems, and data use. The project also piloted the Maturity Index Model in five countries, helping ministries track progress in institutionalising data-driven decision-making.

MakSPH team led by Prof. Rhoda Wanyenze (centre, in red) with Dr. Estifanos Biru Shargie of the Global Fund (to her right) and other delegates at the PERSuADE II Regional Partners Meeting in Harare, Zimbabwe, December 11–14, 2023. The meeting reinforced regional collaboration in strengthening data use and health systems.
MakSPH team led by Prof. Rhoda Wanyenze (centre, in red) with Dr. Estifanos Biru Shargie of the Global Fund (to her right) and other delegates at the PERSuADE II Regional Partners Meeting in Harare, Zimbabwe, December 11–14, 2023. The meeting reinforced regional collaboration in strengthening data use and health systems.

In Uganda, the PERSuADE project was implemented in Kiboga, Buikwe, Kasanda, Mukono, and Mityana districts, selected by the Ministry of Health. According to the Principal Investigator, Prof. Rhoda Wanyenze, strengthening data analysis and use has greatly enhanced the capacity of Ministries of Health to deliver targeted interventions that directly benefit communities. She noted that improved analytical skills at national and subnational levels now enable ministries to identify disparities in HIV, TB, and malaria burdens, while district and facility health workers can use data to strengthen local service delivery. “With better data, districts can plan more efficiently, allocate medicines, and implement tailored prevention campaigns to address specific risks, raise awareness, and reduce new infections,” she said, emphasising the role of equitable collaboration as a key success factor in Uganda and across the continent for this partnership.

Indeed, during a learning visit to Uganda in September 2024, Dr. Estifanos Biru Shargie, Senior Specialist for Monitoring, Evaluation, and Country Analysis at the Global Fund, commended the PERSuADE Project for strengthening local capacity and fostering sustainable health system improvements through South-South partnerships among schools and ministries. “The impact has been significant. In Kiboga, I was impressed by how teams mapped gaps in services and addressed them over four years, using data to inform decisions and monitor progress. Working with Makerere University School of Public Health has been an honour. The School blends academic excellence with practical implementation, backed by strong financial management and a long-standing relationship with the Ministry of Health. Their coordination, networking, and efficiency have been exemplary,” Dr. Shargie said.

Another currently ongoing initiative at the School is the African Leadership and Management Training for Impact in Malaria Eradication (ALAMIME) program, led by MakSPH with ten participating institutions across nine malaria-endemic countries, funded by the Bill & Melinda Gates Foundation. Co-led by Prof. Elizeus Rutebemberwa and Prof. Dosithée Ngo Bebe, ALAMIME is cultivating the leadership Africa needs to defeat malaria by strengthening institutions, building capacity, and fostering regional networks. In 2024 alone, the program trained over 250 participants, nearly half women, from national malaria programs, ministries, and NGOs. Through structured training, alumni-led webinars, and cross-country exchanges, the program has demonstrated how equitable, multi-country partnerships translate investment into sustainable systems and shared momentum toward malaria elimination.

During MakSPH@70 celebrations in December 2024, Hon. Margaret Muhanga, State Minister for Primary Health Care, launched the School’s new five-year Strategic Plan alongside key partners from the Ministry of Health, WHO, and Makerere University leadership, including Council Chairperson Ms. Lorna Magara, Vice Chancellor Prof. Barnabas Nawangwe, and Dean Prof. Rhoda Wanyenze. The Plan places partnerships at the heart of MakSPH’s vision for public health impact and comes at a defining moment as the School regains standalone status within Makerere University.
During MakSPH@70 celebrations in December 2024, Hon. Margaret Muhanga, State Minister for Primary Health Care, launched the School’s new five-year Strategic Plan alongside key partners from the Ministry of Health, WHO, and Makerere University leadership, including Council Chairperson Ms. Lorna Magara, Vice Chancellor Prof. Barnabas Nawangwe, and Dean Prof. Rhoda Wanyenze. The Plan places partnerships at the heart of MakSPH’s vision for public health impact and comes at a defining moment as the School regains standalone status within Makerere University.

For nearly 15 years now, MakSPH has also hosted the NTU–Mak Partnership, a collaboration between Makerere University and Nottingham Trent University, first conceived in 2010, with Assoc. Prof. David Musoke and Prof. Linda Gibson as the Uganda and UK Co-Leads. One of the key reasons for the success of this partnership is equity, and it has since attracted over £1.4 million in grants, trained more than 900 Village Health Teams in Wakiso District, supported over 350 practitioners in antimicrobial stewardship, and facilitated exchanges for more than 200 students and faculty. It has also equipped community health workers to respond to non-communicable diseases, antimicrobial resistance, and the COVID-19 pandemic, while generating over 30 peer-reviewed publications and convening global platforms such as the first International Community Health Worker Symposium, held in Kampala in 2017.

Dr. Musoke, the Co-Principal Investigator for the project on strengthening equitable research collaborations in Uganda, described the NTU-Mak partnership as a model North–South partnership that has produced both joint scholarship and lasting institutional ties. He noted that its success has inspired wider collaborations, as the current project on equitable partnerships builds on this foundation. Emerging from a British Academy regional workshop in Nairobi in 2024, MakSPH extended its engagement to Mountains of the Moon University (MMU), Uganda Martyrs University (UMU), and the National Agricultural Research Organisation (NARO). Together with Nottingham Trent University, these institutions are now advancing reforms to embed equity in research partnerships across Uganda’s research ecosystem.

Assoc. Prof. David Musoke, Mr. Awel Uwihanganye, and the MakSPH Equitable Partnerships Project Team during the workshop on equitable partnerships. August 20, 2025. Workshop on Strengthening Equitable Partnerships in International Research Collaboration in Uganda, keynote address by Prof. David Musoke Serwadda,20th August 2025, Makerere University School of Public Health (MakSPH) Auditorium, Kampala Uganda, East Africa.
Assoc. Prof. David Musoke, Mr. Awel Uwihanganye, and the MakSPH Equitable Partnerships Project Team during the workshop on equitable partnerships. August 20, 2025.

View on MakSPH

John Okeya

Continue Reading

Trending